184.52
price down icon2.30%   -4.35
after-market After Hours: 184.52
loading
Ligand Pharmaceuticals Inc stock is traded at $184.52, with a volume of 172.74K. It is down -2.30% in the last 24 hours and up +6.58% over the past month. Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
See More
Previous Close:
$188.87
Open:
$187.8
24h Volume:
172.74K
Relative Volume:
0.78
Market Cap:
$3.62B
Revenue:
$152.42M
Net Income/Loss:
$45.24M
P/E Ratio:
73.51
EPS:
2.51
Net Cash Flow:
$6.97M
1W Performance:
-0.57%
1M Performance:
+6.58%
6M Performance:
+65.67%
1Y Performance:
+59.72%
1-Day Range:
Value
$182.87
$191.88
1-Week Range:
Value
$182.87
$194.44
52-Week Range:
Value
$93.58
$194.44

Ligand Pharmaceuticals Inc Stock (LGND) Company Profile

Name
Name
Ligand Pharmaceuticals Inc
Name
Phone
858-550-7500
Name
Address
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Name
Employee
68
Name
Twitter
@Ligand_LGND
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
LGND's Discussions on Twitter

Compare LGND with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LGND
Ligand Pharmaceuticals Inc
184.52 3.68B 152.42M 45.24M 6.97M 2.51
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
417.21 108.30B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
652.91 69.37B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.59 62.38B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
821.97 51.50B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
166.95 34.94B 398.11M -1.03B -868.57M -5.7032

Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-10-25 Initiated Stifel Buy
Oct-03-24 Initiated Oppenheimer Outperform
Jul-30-24 Initiated RBC Capital Mkts Outperform
Apr-14-21 Resumed Stephens Overweight
Feb-04-21 Reiterated H.C. Wainwright Buy
Oct-06-20 Initiated Barclays Overweight
Mar-24-20 Downgrade Argus Buy → Hold
Mar-10-20 Initiated Guggenheim Neutral
Feb-06-20 Initiated The Benchmark Company Buy
Sep-19-19 Upgrade Barclays Equal Weight → Overweight
Jun-11-19 Initiated Barclays Equal Weight
May-03-19 Reiterated H.C. Wainwright Buy
Mar-06-19 Reiterated H.C. Wainwright Buy
Oct-29-18 Upgrade ROTH Capital Neutral → Buy
Oct-02-18 Reiterated H.C. Wainwright Buy
Sep-11-18 Reiterated Argus Buy
Aug-17-18 Initiated Goldman Neutral
Aug-08-18 Downgrade ROTH Capital Buy → Neutral
Jun-21-18 Initiated Argus Buy
Dec-27-17 Reiterated H.C. Wainwright Buy
Sep-05-17 Resumed H.C. Wainwright Buy
Oct-05-16 Reiterated H.C. Wainwright Buy
Aug-05-16 Downgrade Deutsche Bank Hold → Sell
Mar-11-16 Initiated Sidoti Buy
Mar-03-16 Initiated H.C. Wainwright Buy
View All

Ligand Pharmaceuticals Inc Stock (LGND) Latest News

pulisher
07:39 AM

Ligand Pharmaceuticals Reaches Analyst Target Price - Nasdaq

07:39 AM
pulisher
07:11 AM

Is Ligand Pharmaceuticals Incorporated (LGDN) stock attractive post correctionStock Surge & Free High Accuracy Swing Entry Alerts - newser.com

07:11 AM
pulisher
06:49 AM

What institutional flow reveals about Ligand Pharmaceuticals IncorporatedWeekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - newser.com

06:49 AM
pulisher
04:05 AM

Intraday pattern recognizer results for Ligand Pharmaceuticals IncorporatedJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com

04:05 AM
pulisher
03:45 AM

Short interest data insights for Ligand Pharmaceuticals Incorporated2025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com

03:45 AM
pulisher
03:27 AM

What catalysts could drive Ligand Pharmaceuticals Incorporated stock higherPortfolio Value Report & Low Risk High Win Rate Stock Picks - newser.com

03:27 AM
pulisher
01:43 AM

Can Ligand Pharmaceuticals Incorporated stock sustain market leadership2025 Market Overview & Weekly High Return Opportunities - newser.com

01:43 AM
pulisher
01:33 AM

What analyst consensus says on Ligand Pharmaceuticals Incorporated stockWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com

01:33 AM
pulisher
12:48 PM

Can technical indicators confirm Ligand Pharmaceuticals Incorporated’s reversalQuarterly Market Review & Community Consensus Trade Signals - newser.com

12:48 PM
pulisher
Oct 28, 2025

Why Ligand Pharmaceuticals Incorporated stock is a value investor pickJuly 2025 Chart Watch & Real-Time Stock Entry Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

How to use Fibonacci retracement on Ligand Pharmaceuticals IncorporatedQuarterly Profit Review & Verified Momentum Watchlists - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Technical signs of recovery in Ligand Pharmaceuticals IncorporatedPortfolio Update Summary & Verified High Yield Trade Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Ligand Pharmaceuticals Incorporated reversing from oversold territoryStop Loss & Intraday High Probability Setup Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Does Ligand Pharmaceuticals Incorporated show high probability of reboundJuly 2025 Review & Weekly High Potential Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-28 01:03:19 - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How Ligand Pharmaceuticals Incorporated (LGDN) stock compares with market leadersCPI Data & Daily Oversold Bounce Ideas - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Analyzing drawdowns of Ligand Pharmaceuticals Incorporated with statistical tools2025 Macro Impact & Low Risk Entry Point Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Ligand Pharmaceuticals Incorporated stock daily chart insightsWeekly Profit Report & Community Driven Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will Ligand Pharmaceuticals Incorporated outperform the market2025 Trading Recap & Risk Controlled Swing Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Price action breakdown for Ligand Pharmaceuticals IncorporatedJuly 2025 Summary & Daily Stock Trend Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Ligand Pharmaceuticals Incorporated forming a reversal patternPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Chart overlay techniques for tracking Ligand Pharmaceuticals IncorporatedWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Is Ligand Pharmaceuticals Incorporated a good long term investmentRetail Trading Trends & Beat the Market with AI Reports - earlytimes.in

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 22:30:09 - newser.com

Oct 26, 2025

Ligand Pharmaceuticals Inc Stock (LGND) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.67
price up icon 0.71%
$90.18
price down icon 1.60%
$28.95
price down icon 0.62%
$103.35
price down icon 1.60%
biotechnology ONC
$314.85
price down icon 0.63%
$166.95
price up icon 1.00%
Cap:     |  Volume (24h):